Loncar China BioPharma ETF (CHNA) Stock Price, News & Analysis

Name: Loncar China BioPharma ETF (CHNA) Financial Data & Stock Overview
Creator: Stock Titan
License: https://www.stocktitan.net/terms-of-use

CHNA

Company Description

This page collects what Stock Titan holds for CHNA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

Last updated:

Performance 1 year

Market Cap

Shares outstanding

Latest News

View All

February 27, 2024

0.00%

Fundamental Income Increases Monthly Cash Dividend for the Net Lease Corporate Real Estate ETF by 5.26%

dividends

January 23, 2024

0.00%

$QTUM, Defiance’s Quantum Computing ETF, Surpasses $200 Million in Assets

October 23, 2023

-27.79%

EXCHANGE TRADED CONCEPTS, LLC., ANNOUNCES COMPLETION OF FUND REORGANIZATION

May 10, 2023

+0.04%

Fundamental Income’s Net Lease Real Estate ETF (NETL) Earns 5-Star Overall Rating from Morningstar

October 24, 2022

-10.11%

Defiance ETFs’ 5G ETF ($FIVG) Earned #1 Ranking out of all 5-Star Morningstar Ratings funds in Communications Sector over 3-year period

June 28, 2022

-1.19%

AIIQ Fund Closure Announcement

Loncar China BioPharma ETF has 7 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. Key topics include dividends. View all CHNA news →

SEC Filings

View All

No SEC filings available for CHNA.

Financial Highlights

—

Revenue (latest FY)

—

Net Income (latest FY)

—

Diluted EPS (latest FY)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months